Beyond Lipid Lowering: What Have We Learned About the Benefits of Statins from the Acute Coronary Syndromes Trials?
- 4 December 2006
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 98 (11), S18-S25
- https://doi.org/10.1016/j.amjcard.2006.09.016
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Oxidative Biomarkers in the Diagnosis and Prognosis of Cardiovascular DiseaseThe American Journal of Cardiology, 2006
- Molecular Basis of Differences Among Statins and a Comparison with Antioxidant VitaminsThe American Journal of Cardiology, 2006
- Plaque Stabilization: Can We Turn Theory into Evidence?The American Journal of Cardiology, 2006
- Inflammatory Biomarkers in Stable AtherosclerosisThe American Journal of Cardiology, 2006
- From Vulnerable Plaque to Vulnerable PatientCirculation, 2003
- From Vulnerable Plaque to Vulnerable PatientCirculation, 2003
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)Circulation, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)Circulation, 1998